ATE392623T1 - Verfahren für die diagnose von schwerkranken patienten - Google Patents
Verfahren für die diagnose von schwerkranken patientenInfo
- Publication number
- ATE392623T1 ATE392623T1 AT04019308T AT04019308T ATE392623T1 AT E392623 T1 ATE392623 T1 AT E392623T1 AT 04019308 T AT04019308 T AT 04019308T AT 04019308 T AT04019308 T AT 04019308T AT E392623 T1 ATE392623 T1 AT E392623T1
- Authority
- AT
- Austria
- Prior art keywords
- pro
- ill patients
- diagnosis
- endothelin
- adm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/5754—Endothelin, vasoactive intestinal contractor [VIC]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04017403 | 2004-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE392623T1 true ATE392623T1 (de) | 2008-05-15 |
Family
ID=34993078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04019308T ATE392623T1 (de) | 2004-07-22 | 2004-08-13 | Verfahren für die diagnose von schwerkranken patienten |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1619505B1 (de) |
| AT (1) | ATE392623T1 (de) |
| DE (1) | DE602004013135T2 (de) |
| ES (1) | ES2300681T3 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767395B2 (en) | 2005-04-15 | 2010-08-03 | Becton, Dickinson And Company | Diagnosis of sepsis |
| US8906857B2 (en) | 2005-12-01 | 2014-12-09 | B.R.A.H.M.S. Gmbh | Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
| US9829494B2 (en) * | 2005-12-01 | 2017-11-28 | Adrenomed Ag | Methods of treatment using ADM antibodies |
| EP2472258A3 (de) | 2006-04-04 | 2012-11-28 | Singulex, Inc. | Hochempfindliches System und Verfahren zur Troponinanalyse |
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| DE102006034142A1 (de) * | 2006-07-24 | 2008-01-31 | B.R.A.H.M.S. Aktiengesellschaft | Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden |
| DE102006052916A1 (de) * | 2006-11-08 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM |
| DE102006060835A1 (de) * | 2006-12-22 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP |
| DE102007021443A1 (de) * | 2007-05-08 | 2008-11-13 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels NT-proET-1 |
| WO2009123737A2 (en) | 2008-04-03 | 2009-10-08 | Becton, Dickinson And Company | Advanced detection of sepsis |
| JP5584695B2 (ja) * | 2008-11-11 | 2014-09-03 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ａｄｍ及びｂｎｐのレベルを決定することによる心疾患に罹患した患者の予後診断及びリスク評価 |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| EP2583106A1 (de) * | 2010-06-18 | 2013-04-24 | Cézanne S.A.S. | Marker zur prognose und risikobeurteilung von schwangerschaftsbedingter hypertonie und präeklampsie |
| WO2011157446A1 (en) * | 2010-06-18 | 2011-12-22 | B.R.A.H.M.S Gmbh | Biomarkers for the prediction of incident cancer |
| WO2018029214A1 (en) * | 2016-08-09 | 2018-02-15 | B.R.A.H.M.S Gmbh | Histones and/or proadm as markers indicating an adverse event |
| WO2018216580A1 (ja) * | 2017-05-22 | 2018-11-29 | 東ソー株式会社 | アドレノメデュリン濃度変動による予後予測の情報提供方法及びその試薬 |
| DK3682247T3 (da) * | 2017-09-13 | 2022-03-21 | Brahms Gmbh | Proadrenomedullin som markør for unormale blodpladeniveauer |
| EP3608673A1 (de) * | 2018-08-08 | 2020-02-12 | B.R.A.H.M.S GmbH | Pro-adm zur prognose des risikos einer erkrankung, die einen krankenhausaufenthalt bei patienten mit symptomen einer infektionskrankheit erfordert |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613804B2 (en) * | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| DE19847690A1 (de) * | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
-
2004
- 2004-08-13 ES ES04019308T patent/ES2300681T3/es active Active
- 2004-08-13 AT AT04019308T patent/ATE392623T1/de active
- 2004-08-13 EP EP04019308A patent/EP1619505B1/de active Active
- 2004-08-13 DE DE602004013135T patent/DE602004013135T2/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2300681T3 (es) | 2008-06-16 |
| EP1619505B1 (de) | 2008-04-16 |
| EP1619505A2 (de) | 2006-01-25 |
| EP1619505A3 (de) | 2006-02-22 |
| DE602004013135T2 (de) | 2009-07-02 |
| DE602004013135D1 (de) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE392623T1 (de) | Verfahren für die diagnose von schwerkranken patienten | |
| ATE554395T1 (de) | Diagnose septischer komplikationen | |
| Moore et al. | The role of veterinary team effectiveness in job satisfaction and burnout in companion animal veterinary clinics | |
| Morgan et al. | Mortality in levodopa-treated Parkinson's disease | |
| EP2177908A3 (de) | Mit Diabetes assoziierte Marker und Verfahren zur Verwendung davon | |
| ATE537450T1 (de) | Igfbp2-biomarker | |
| Kogan et al. | Veterinarians' experiences with near misses and adverse events | |
| DE602006019262D1 (de) | QUANTITATIVE ASSAYS FÜR PDGFR-beta- IN KÖRPERFLÜSSIGKEITEN | |
| DE602005018264D1 (de) | Künstliches blutgefäss | |
| DE60326214D1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| WO2004097429A3 (en) | Apociii and the treatmentand diagnosis of diabetes | |
| BRPI0511127A (pt) | prouroguanilina e análogos sintéticos ou produtos da clivagem proteolìtica dela derivados, como agentes terapêuticos e de diagnósticos para doenças que envolvem a homeostasia de sal e/ou de lìquidos | |
| AR054909A1 (es) | Modulacion de los receptores activados por el proliferador de peroxisomas | |
| ATE441107T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel des analyten für die extrazelluläre domäne (ecd) des epidermalen wachstumsfaktor-rezeptors (egfr), allein oder in kombination mit anderen analyten, in proben von kírperflüssigkeiten | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| ATE354097T1 (de) | Verfahren zur diagnose von leberfibrose. | |
| ATE411771T1 (de) | Selektive exposition von miniatursonden mit integrierten sensorarrays für kontinuierlichen in-vivo diagnosis | |
| Adejumo et al. | Prevalence, pattern and association of pruritus with quality of life in chronic kidney disease patients attending kidney care centre, Ondo City, Southwest Nigeria | |
| MX2021015445A (es) | Ensayo de quimioluminiscencia a base de oxidasa de leucocitos fagocitica en sangre entera y en fluidos corporales aplicables a las pruebas de diagnostico de punto de cuidado (poc) la medicion de punto de cuidado (poc) de la funcion neutrofila absoluta (anf). | |
| Sudano et al. | Secondary hypertension as a cause of treatment resistance | |
| AR051870A1 (es) | Metodos para el diagnostico y tratamiento de pacientes con enfermedad critica, y el uso de endotelina y agonistas de endotelina con actividad vasoconstrictora en la preparacion de medicamentos para el tratamiento de pacientes con enfermedad critica | |
| Zhuang et al. | The posterolateral mid‐forearm perforator flap: Anatomical study and clinical application | |
| Forrest et al. | Breaking the cycle of pain in interstitial cystitis/painful bladder syndrome: toward standardization of early diagnosis and treatment: consensus panel recommendations | |
| Ruane-McAteer et al. | A cognitive-emotional see-saw: Men’s experiences of undergoing active surveillance for prostate cancer | |
| GB0409153D0 (en) | Method of diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1619505 Country of ref document: EP |